Efficacy and safety of transarterial chemoembolization plus lenvatinib in the treatment of advanced hepatocellular carcinoma: A meta-analysis

BACKGROUND: The benefits of transarterial chemoembolization (TACE) plus lenvatinib in advanced hepatocellular carcinoma (HCC) remain controversial. Therefore, we performed a meta-analysis to evaluate the efficacy and safety of TACE plus lenvatinib in the treatment of advanced HCC. METHODS: Up to Feb...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dailong, Liu, Siqi, Cheng, Chunlai, Xu, Lu, Zhao, Pingfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476746/
https://www.ncbi.nlm.nih.gov/pubmed/37657057
http://dx.doi.org/10.1097/MD.0000000000034811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476746/
https://www.ncbi.nlm.nih.gov/pubmed/37657057
http://dx.doi.org/10.1097/MD.0000000000034811

Ejemplares similares